Protector Forsikring ASA (0JXF)
London Exchange · UK · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 442.70 |
|---|---|
| 52-week range | 399.00 – 556.50 |
| Return, 1 month / 3 months | +0.8% / −10.6% |
| Return, 1 year / 3 years | −7.8% / +197.8% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 25.6% |
| Worst drawdown (1 year) | -24.7% |
| Average daily value traded | 2.53M NOK |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Protector Forsikring ASA is a Norwegian insurance company based in Oslo. It provides property and casualty insurance, focusing on commercial customers such as businesses, public-sector bodies and organisations, and it also offers personal insurance products. The company writes policies across the Nordic region and other European markets, serving customers through insurance brokers and its own distribution channels. Its business centres on underwriting general insurance risks and handling claims for the clients it covers.
Protector Forsikring ASA trades under the code 0JXF on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Protector Forsikring ASA (0JXF) trades on the London Exchange in UK. It last closed at NOK 442.70 on 22 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 2,012 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.8% and over the last three months it fell 10.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.8% | ||
| From 52-week high | -19.9% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.6% | ||
| 6-month return | -8.2% | ||
| 12-month return, skipping the last month | -8.5% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.7% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.53M NOK | ||
| Zero-volume days | 6.7% | ||
| Income | 78 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | +0.8% |
| 3 months | −10.6% |
| 6 months | −8.2% |
| 1 year | −7.8% |
| 3 years | +197.8% |
| 5 years | +541.5% |
Signals
| 50-day / 200-day average | 451.48 / 474.89 |
|---|---|
| Golden / death cross (60 days) | Death, 26 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 10.94 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Jul 2026 | NOK 3.0000 |
| 28 Apr 2026 | NOK 8.0000 |
| 3 Feb 2026 | NOK 6.0000 |
| 28 Oct 2025 | NOK 3.0000 |
| 16 Jul 2025 | NOK 2.0000 |
| 30 Apr 2025 | NOK 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.